pubmed-article:1350262 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C1710263 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C0005778 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C0042974 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C0019266 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C0314603 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C1879746 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C1547011 | lld:lifeskim |
pubmed-article:1350262 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:1350262 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:1350262 | pubmed:dateCreated | 1992-6-19 | lld:pubmed |
pubmed-article:1350262 | pubmed:abstractText | Twenty-five patients with von Willebrand's disease (vWD) type III were analysed with regard to blood coagulation variables and possible deletions. Nine of the probands and their families were further investigated with DNA linkage analyses. Different patterns of heredity can be suggested in our families with vWD type III, on the basis of blood coagulation analyses. The findings suggest homozygosity in five families and the possibility of compound heterozygosity or a new mutation in the proband in three families. The linkage analyses confirm the results of the coagulation analyses. The segregation of the von Willebrand factor (vWF) gene can be followed in the families, and carrier diagnosis can be made in several of the probands' relatives. The possibility of large deletions in the vWF gene of the probands and their parents was investigated with probes representing the whole vWF cDNA. No deletions were found. | lld:pubmed |
pubmed-article:1350262 | pubmed:language | eng | lld:pubmed |
pubmed-article:1350262 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1350262 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1350262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1350262 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1350262 | pubmed:month | May | lld:pubmed |
pubmed-article:1350262 | pubmed:issn | 0340-6717 | lld:pubmed |
pubmed-article:1350262 | pubmed:author | pubmed-author:BlombäckMM | lld:pubmed |
pubmed-article:1350262 | pubmed:author | pubmed-author:SöderlindEE | lld:pubmed |
pubmed-article:1350262 | pubmed:author | pubmed-author:AnvretMM | lld:pubmed |
pubmed-article:1350262 | pubmed:author | pubmed-author:LindstedtMM | lld:pubmed |
pubmed-article:1350262 | pubmed:author | pubmed-author:Tapper-Persso... | lld:pubmed |
pubmed-article:1350262 | pubmed:author | pubmed-author:ThelanderA... | lld:pubmed |
pubmed-article:1350262 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1350262 | pubmed:volume | 89 | lld:pubmed |
pubmed-article:1350262 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1350262 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1350262 | pubmed:pagination | 147-54 | lld:pubmed |
pubmed-article:1350262 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:meshHeading | pubmed-meshheading:1350262-... | lld:pubmed |
pubmed-article:1350262 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1350262 | pubmed:articleTitle | Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity. | lld:pubmed |
pubmed-article:1350262 | pubmed:affiliation | Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden. | lld:pubmed |
pubmed-article:1350262 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1350262 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1350262 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1350262 | lld:pubmed |